Reactive Oxygen Species in Cardiometabolic Syndrome, Neuronal Diseases and Cancer

Esma R. Isenovic, PhD is a full professor/principal research fellow and Head of the Laboratory for Endocrinology, Hypertension, and Metabolic Diseases in the Department of Radiobiology and Molecular Genetics at the "VINA" Institute of Nuclear Sciences - National Institute of The Republic of Serbia, University of Belgrade, Serbia. Professor Isenovic's research interests over the last 25 years have been diabetes and cardiovascular diseases and the effects of various hormones on cardiovascular biology. She serves as an invited reviewer for 181 international scientific journals, on the Editorial Boards of 26 international scientific journals, and on the editorial boards of twelve international journals. Professor Isenovic has extensive experience in the international research program and proposal evaluation as an expert reviewer. She has published over 200 scientific papers in peer-reviewed journals and 24 book chapters.Dr. Jasjit Suri, PhD, MBA, is a renowned innovator and scientist. He received the Director General’s Gold Medal in 1980 and is a Fellow of several prestigious organizations, including the American Institute of Medical and Biological Engineering and the Institute of Electrical and Electronics Engineers. Dr. Suri has been honored with lifetime achievement awards from Marcus, NJ, USA, and Graphics Era University, India. He has published nearly 300 peer-reviewed AI articles, 100 books, and holds 100 innovations/trademarks, achieving an H-index of nearly 100 with about 43,000 citations. Dr. Suri has served as chairman of AtheroPoint, IEEE Denver section, and as an advisory board member to various healthcare industries and universities globally.

• Section 1. Introduction to ROS 1. ROS in general2. ROS signaling3. ROS and regulation of gene expressionSection 2. ROS in cardiometabolic syndrome 4. Molecular Mechanisms of ROS in cardiometabolic syndrome5. Molecular Mechanisms of ROS and Regulation of Gene expression in cardiometabolic syndrome6. Antioxidant supplementation and Cardiometabolic syndromeSection 3. ROS and neuronal diseases7. Molecular Mechanisms of ROS in neurodegenerative diseases (Alzheimer, Parkinson, etc.)8. ROS and psychiatric diseases (schizophrenia, etc.)9. Antioxidant supplementation and neuronal diseasesSection 4. ROS and cancer10. ROS and early stage of cancer (cancer development)11. ROS and late-stage cancer (cancer metastasis)12. Antioxidant supplementation and cancerSection 5. Summary and concluding remarks

Select Guide Rating